Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Beata Styrc"'
Autor:
Aureliusz Kolonko, Rafał Ficek, Beata Styrc, Michał Sobolewski, Roksana Stankowska, Jerzy Chudek, Andrzej Więcek
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 23, Iss 12, p 386 (2022)
Background: Carotid atherosclerosis is one of the main cerebrovascular complications in kidney transplant recipients (KTRs). We analyzed the relationships between carotid intima-media thickness (IMT) and the occurrence and characteristics of carotid
Externí odkaz:
https://doaj.org/article/15f0643d07654b68bc0c9f96925a31a6
Autor:
Aureliusz Kolonko, Beata Bzoma, Piotr Giza, Beata Styrc, Michał Sobolewski, Jerzy Chudek, Alicja Dębska-Ślizień, Andrzej Więcek
Publikováno v:
Medicina, Vol 54, Iss 5, p 66 (2018)
Background: The panel-reactive antibodies that use the complement-dependent cytotoxicity test (PRA-CDC) are still a standard method for monitoring the degree of immunization in kidney transplant candidates on active waiting lists in some countries, i
Externí odkaz:
https://doaj.org/article/cbf39832d2734484baf1da4c238558d3
Autor:
Andrzej Więcek, Jerzy Chudek, Roksana Stankowska, Michał Sobolewski, Beata Styrc, Rafał Ficek, Aureliusz Kolonko
Publikováno v:
Reviews in Cardiovascular Medicine. 23:386
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3057f26dccbbdc41f94426619a7b12bc
https://doi.org/10.31083/j.rcm2312386
https://doi.org/10.31083/j.rcm2312386
Publikováno v:
Clinical transplantationREFERENCES. 33(10)
Antithymocyte globulin (ATG) is widely used as an induction therapy after kidney transplantation. The present study aimed to compare the effectiveness and safety of induction therapy between two ATG formulations, Grafalon (FreseniusThis study include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e1482dfb42c8d9ebcdf54222fc05a8
https://pubmed.ncbi.nlm.nih.gov/31365162
https://pubmed.ncbi.nlm.nih.gov/31365162
Autor:
Andrzej Wiecek, Piotr Giza, Beata Styrc, Aureliusz Kolonko, Michał Sobolewski, Jerzy Chudek, Alicja Dębska-Ślizień, Beata Bzoma
Publikováno v:
Medicina
Medicina, Vol 54, Iss 5, p 66 (2018)
Medicina; Volume 54; Issue 5; Pages: 66
Volume 54
Issue 5
Medicina, Vol 54, Iss 5, p 66 (2018)
Medicina; Volume 54; Issue 5; Pages: 66
Volume 54
Issue 5
Background: The panel-reactive antibodies that use the complement-dependent cytotoxicity test (PRA-CDC) are still a standard method for monitoring the degree of immunization in kidney transplant candidates on active waiting lists in some countries, i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a62467a00e32526458d0c3cc378be598
https://doi.org/10.3390/medicina54050066
https://doi.org/10.3390/medicina54050066